A UK multicentre audit of the management of patients with primary hypercholesterolaemia or mixed dyslipidaemia with bempedoic acid against published lipid-lowering treatment targets

• Main Authors: Sudarshan Ramachandran (Author), Amro Maarouf (Author), Karen Mitchell (Author), Tony Avades (Author), Peter Smith (Author), Lee Boulton (Author), Jennifer Kelly (Author), Nitasha Vekaria (Author), Elizabeth Hughes (Author)
• Format: Book
• Published: BioExcel Publishing Ltd, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Bempedoic acid, an adenosine triphosphate citrate lyase inhibitor, was introduced to UK practice via a pre-reimbursement access scheme for adults with primary hypercholesterolaemia or mixed dyslipidaemia who are at high risk of cardiovascular disease, in whom statins are either not toler...